This inventor holds 1 USPTO granted patent. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Mamoru Tobisu: Innovator in Thrombin Receptor Antagonism
Introduction
Mamoru Tobisu is a notable inventor based in Minoh, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of thrombin receptor antagonists. His work is essential for advancing treatments for various pathological conditions.
Latest Patents
Mamoru Tobisu holds a patent for a triazole derivative and its use as a thrombin receptor antagonist. The invention relates to a compound represented by a specific formula, which includes various substituents that enhance its therapeutic efficacy. This thrombin receptor antagonist, particularly targeting PAR-1, is useful for the prophylaxis or treatment of diseases mediated by PAR-1.
Career Highlights
Mamoru Tobisu is associated with Takeda Pharmaceutical Company Limited, a leading global pharmaceutical company. His role at Takeda has allowed him to focus on innovative drug development, contributing to the advancement of medical science.
Collaborations
Throughout his career, Mamoru has collaborated with esteemed colleagues such as Eiji Honda and Yoshiyuki Fukase. These collaborations have fostered a productive environment for research and innovation in the pharmaceutical industry.
Conclusion
Mamoru Tobisu's contributions to the field of thrombin receptor antagonism exemplify the impact of innovative thinking in medicine. His patent and work at Takeda Pharmaceutical Company Limited highlight the importance of research in developing effective treatments for complex diseases.